|Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association|
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
|Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association|
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), 434-441, 2015
|Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …|
JD Douketis, AC Spyropoulos, FA Spencer, M Mayr, AK Jaffer, ...
Chest 141 (2), e326S-e350S, 2012
|A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism|
C Kearon, M Gent, J Hirsh, J Weitz, MJ Kovacs, DR Anderson, AG Turpie, ...
New England Journal of Medicine 340 (12), 901-907, 1999
|2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]|
DCW Lau, JD Douketis, KM Morrison, IM Hramiak, AM Sharma, E Ur
Cmaj 176 (8), S1-S13, 2007
|Systematic overview of warfarin and its drug and food interactions|
AM Holbrook, JA Pereira, R Labiris, H McDonald, JD Douketis, ...
Archives of internal medicine 165 (10), 1095-1106, 2005
|Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …|
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
|A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome|
MA Crowther, JS Ginsberg, J Julian, J Denburg, J Hirsh, J Douketis, ...
New England Journal of Medicine 349 (12), 1133-1138, 2003
|Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis|
LA Linkins, PT Choi, JD Douketis
Annals of internal medicine 139 (11), 893-900, 2003
|Perioperative bridging anticoagulation in patients with atrial fibrillation|
JD Douketis, AC Spyropoulos, S Kaatz, RC Becker, JA Caprini, AS Dunn, ...
New England Journal of Medicine 373 (9), 823-833, 2015
|Risk of fatal pulmonary embolism in patients with treated venous thromboembolism|
JD Douketis, C Kearon, S Bates, EK Duku, JS Ginsberg
Jama 279 (6), 458-462, 1998
|Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice|
JD Douketis, C Macie, L Thabane, DF Williamson
International journal of obesity 29 (10), 1153-1167, 2005
|Low-molecular-weight heparin in the treatment of patients with venous thromboembolism|
New England Journal of Medicine 337 (10), 657-662, 1997
|A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding …|
LR Dolovich, JS Ginsberg, JD Douketis, AM Holbrook, G Cheah
Archives of internal medicine 160 (2), 181-188, 2000
|Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials|
JW Eikelboom, DJ Quinlan, JD Douketis
The Lancet 358 (9275), 9-15, 2001
|Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients|
F Dentali, JD Douketis, M Gianni, W Lim, MA Crowther
Annals of Internal Medicine 146 (4), 278-288, 2007
|Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY …|
JS Healey, J Eikelboom, J Douketis, L Wallentin, J Oldgren, S Yang, ...
Circulation 126 (3), 343-348, 2012
|Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes|
F Botto, P Alonso-Coello, MTV Chan, JC Villar, D Xavier, S Srinathan, ...
Anesthesiology 120 (3), 564-578, 2014
|Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors|
S Kaatz, PA Kouides, DA Garcia, AC Spyropolous, M Crowther, ...
American journal of hematology 87 (S1), S141-S145, 2012
|Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates|
D Siegal, J Yudin, S Kaatz, JD Douketis, W Lim, AC Spyropoulos
Circulation 126 (13), 1630-1639, 2012